2024-02-15 |
2024-02-14 |
V
Vente
|
Litchfield Caroline
EVP & CFO
Dirigeant
|
38 291
-42.9%
125,50
4 805 521
USD
|
38 291
-42.9%
|
125,50
|
4 805 521
USD
|
|
2024-02-15 |
2024-02-14 |
V
Vente
|
Davis Robert M
Chairman, CEO & President
Administrateur exécutif
|
85 021
-19.6%
125,40
10 661 574
USD
|
85 021
-19.6%
|
125,40
|
10 661 574
USD
|
|
2024-02-15 |
2024-02-13 |
V
Vente
|
Davis Robert M
Chairman, CEO & President
Administrateur exécutif
|
25 324
-6.8%
126,37
3 200 277
USD
|
25 324
-6.8%
|
126,37
|
3 200 277
USD
|
|
2024-02-15 |
2024-02-13 |
V
Vente
|
Davis Robert M
Chairman, CEO & President
Administrateur exécutif
|
124 676
-25.0%
125,74
15 677 147
USD
|
124 676
-25.0%
|
125,74
|
15 677 147
USD
|
|
2024-02-14 |
2024-02-13 |
V
Vente
|
Romanelli Joseph
President, Human Health Int?l
Dirigeant
|
1 000
-4.9%
124,89
124 888
USD
|
1 000
-4.9%
|
124,89
|
124 888
USD
|
|
2024-02-12 |
2024-02-09 |
V
Vente
|
Li Dean Y
Executive VP & President, MRL
Dirigeant
|
14 702
-24.1%
125,50
1 845 083
USD
|
14 702
-24.1%
|
125,50
|
1 845 083
USD
|
|
2024-02-08 |
2024-02-07 |
V
Vente
|
Williams David Michael
EVP,Chief Info&Digital Officer
Dirigeant
|
1 451
-6.8%
127,57
185 108
USD
|
1 451
-6.8%
|
127,57
|
185 108
USD
|
|
2024-02-05 |
2024-02-02 |
V
Vente
|
Oosthuizen Johannes Jacobus
President, U.S. Market
Dirigeant
|
18 959
-44.8%
127,18
2 411 111
USD
|
18 959
-44.8%
|
127,18
|
2 411 111
USD
|
|
2024-02-02 |
2024-02-02 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
50 694
-68.2%
126,65
6 420 349
USD
|
50 694
-68.2%
|
126,65
|
6 420 349
USD
|
|
2024-02-02 |
2024-02-02 |
V
Vente
|
Zachary Jennifer
EVP, General Counsel
Dirigeant
|
49 499
-63.0%
126,97
6 284 779
USD
|
49 499
-63.0%
|
126,97
|
6 284 779
USD
|
|
2023-11-13 |
2023-11-09 |
V
Vente
|
Oosthuizen Johannes Jacobus
President, U.S. Market
Dirigeant
|
2 081
-10.3%
102,38
213 061
USD
|
2 081
-10.3%
|
102,38
|
213 061
USD
|
|
2023-11-09 |
2023-11-08 |
V
Vente
|
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Dirigeant
|
43 823
-28.2%
105,03
4 602 668
USD
|
43 823
-28.2%
|
105,03
|
4 602 668
USD
|
|
2023-08-15 |
2023-08-14 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
4 250
-15.6%
109,01
463 293
USD
|
4 250
-15.6%
|
109,01
|
463 293
USD
|
|
2023-08-04 |
2023-08-03 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
4 500
-14.2%
105,49
474 701
USD
|
4 500
-14.2%
|
105,49
|
474 701
USD
|
|
2023-08-03 |
2023-08-02 |
V
Vente
|
Romanelli Joseph
President, Human Health Int?l
Dirigeant
|
59
-100.0%
107,37
6 335
USD
|
59
-100.0%
|
107,37
|
6 335
USD
|
|
2023-08-03 |
2023-08-02 |
V
Vente
|
Romanelli Joseph
President, Human Health Int?l
Dirigeant
|
30
-0.1%
107,37
3 221
USD
|
30
-0.1%
|
107,37
|
3 221
USD
|
|
2023-05-05 |
2023-05-04 |
V
Vente
|
Karachun Rita A
Sr. VP Fince-Global Controller
Dirigeant
|
15 875
-25.8%
117,53
1 865 843
USD
|
15 875
-25.8%
|
117,53
|
1 865 843
USD
|
|
2023-05-05 |
2023-05-04 |
V
Vente
|
Zachary Jennifer
EVP, General Counsel
Dirigeant
|
19 141
-35.3%
117,59
2 250 834
USD
|
19 141
-35.3%
|
117,59
|
2 250 834
USD
|
|
2023-05-05 |
2023-05-03 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
13 400
-29.7%
119,01
1 594 734
USD
|
13 400
-29.7%
|
119,01
|
1 594 734
USD
|
|
2023-05-05 |
2023-05-03 |
VP
Vente planifiée
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
12 000
-26.6%
119,01
1 428 089
USD
|
12 000
-26.6%
|
119,01
|
1 428 089
USD
|
|
2023-05-05 |
2023-05-03 |
VP
Vente planifiée
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
15 000
-25.0%
119,01
1 785 122
USD
|
15 000
-25.0%
|
119,01
|
1 785 122
USD
|
|
2023-05-05 |
2023-05-03 |
VP
Vente planifiée
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
13 000
-17.8%
119,01
1 547 112
USD
|
13 000
-17.8%
|
119,01
|
1 547 112
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Williams David Michael
EVP,Chief Info&Digital Officer
Dirigeant
|
7 509
-40.4%
116,82
877 222
USD
|
7 509
-40.4%
|
116,82
|
877 222
USD
|
|
2023-05-02 |
2023-05-01 |
V
Vente
|
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Dirigeant
|
75 436
-32.8%
116,03
8 752 749
USD
|
75 436
-32.8%
|
116,03
|
8 752 749
USD
|
|
2023-05-02 |
2023-04-28 |
V
Vente
|
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Dirigeant
|
66 163
-30.0%
115,00
7 608 844
USD
|
66 163
-30.0%
|
115,00
|
7 608 844
USD
|
|
2023-04-28 |
2023-04-28 |
V
Vente
|
Davis Robert M
Chairman, CEO & President
Administrateur exécutif
|
143 329
-34.5%
114,93
16 472 845
USD
|
143 329
-34.5%
|
114,93
|
16 472 845
USD
|
|
2023-04-14 |
2023-04-13 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
67 892
-100.0%
115,07
7 812 366
USD
|
67 892
-100.0%
|
115,07
|
7 812 366
USD
|
|
2023-04-14 |
2023-04-13 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
66 163
-49.4%
115,06
7 612 702
USD
|
66 163
-49.4%
|
115,06
|
7 612 702
USD
|
|
2023-02-16 |
2023-02-15 |
V
Vente
|
Romanelli Joseph
President, Human Health Int?l
Dirigeant
|
5 000
-19.8%
108,22
541 101
USD
|
5 000
-19.8%
|
108,22
|
541 101
USD
|
|
2023-02-14 |
2023-02-13 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
1 815
-5.2%
109,10
198 017
USD
|
1 815
-5.2%
|
109,10
|
198 017
USD
|
|
2023-02-10 |
2023-02-09 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
5 000
-12.5%
107,00
535 007
USD
|
5 000
-12.5%
|
107,00
|
535 007
USD
|
|
2023-02-08 |
2023-02-06 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
4 436
-10.0%
104,25
462 473
USD
|
4 436
-10.0%
|
104,25
|
462 473
USD
|
|
2023-02-06 |
2023-02-03 |
V
Vente
|
Zachary Jennifer
EVP, General Counsel
Dirigeant
|
75 436
-58.3%
103,17
7 782 762
USD
|
75 436
-58.3%
|
103,17
|
7 782 762
USD
|
|
2023-01-11 |
2023-01-09 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
1 702
-5.5%
114,46
194 813
USD
|
1 702
-5.5%
|
114,46
|
194 813
USD
|
|
2023-01-11 |
2023-01-09 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
38 216
-55.1%
113,78
4 348 033
USD
|
38 216
-55.1%
|
113,78
|
4 348 033
USD
|
|
2023-01-11 |
2023-01-09 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
3 940
-5.4%
112,78
444 362
USD
|
3 940
-5.4%
|
112,78
|
444 362
USD
|
|
2023-01-11 |
2023-01-09 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
4 538
-5.8%
111,73
507 048
USD
|
4 538
-5.8%
|
111,73
|
507 048
USD
|
|
2023-01-11 |
2023-01-09 |
VP
Vente planifiée
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
35 598
-31.4%
110,61
3 937 659
USD
|
35 598
-31.4%
|
110,61
|
3 937 659
USD
|
|
2022-11-10 |
2022-11-10 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
15 000
-31.8%
101,42
1 521 278
USD
|
15 000
-31.8%
|
101,42
|
1 521 278
USD
|
|
2022-11-10 |
2022-11-09 |
V
Vente
|
Oosthuizen Johannes Jacobus
President, U.S. Market
Dirigeant
|
1 795
-9.7%
103,21
185 262
USD
|
1 795
-9.7%
|
103,21
|
185 262
USD
|
|
2022-11-10 |
2022-11-09 |
V
Vente
|
Davis Robert M
CEO & President
Administrateur exécutif
|
100
-0.0%
103,59
10 359
USD
|
100
-0.0%
|
103,59
|
10 359
USD
|
|
2022-11-10 |
2022-11-09 |
V
Vente
|
Davis Robert M
CEO & President
Administrateur exécutif
|
79 918
-24.4%
102,98
8 229 924
USD
|
79 918
-24.4%
|
102,98
|
8 229 924
USD
|
|
2022-11-10 |
2022-11-09 |
V
Vente
|
Davis Robert M
CEO & President
Administrateur exécutif
|
87 595
-21.1%
101,94
8 929 557
USD
|
87 595
-21.1%
|
101,94
|
8 929 557
USD
|
|
2022-11-10 |
2022-11-08 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
20 000
-38.4%
101,00
2 020 000
USD
|
20 000
-38.4%
|
101,00
|
2 020 000
USD
|
|
2022-11-08 |
2022-11-07 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
84 721
-10.8%
100,07
8 477 717
USD
|
84 721
-10.8%
|
100,07
|
8 477 717
USD
|
|
2022-11-08 |
2022-11-07 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
126 134
-13.8%
99,42
12 540 835
USD
|
126 134
-13.8%
|
99,42
|
12 540 835
USD
|
|
2022-11-08 |
2022-11-07 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
24 914
-2.7%
98,45
2 452 880
USD
|
24 914
-2.7%
|
98,45
|
2 452 880
USD
|
|
2022-11-07 |
2022-11-07 |
V
Vente
|
Oosthuizen Johannes Jacobus
President, U.S. Market
Dirigeant
|
45 561
-71.1%
99,47
4 531 980
USD
|
45 561
-71.1%
|
99,47
|
4 531 980
USD
|
|
2022-11-07 |
2022-11-04 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
34 810
-4.7%
99,08
3 448 989
USD
|
34 810
-4.7%
|
99,08
|
3 448 989
USD
|
|
2022-11-07 |
2022-11-04 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
200 190
-21.4%
98,53
19 725 241
USD
|
200 190
-21.4%
|
98,53
|
19 725 241
USD
|
|
2022-11-07 |
2022-11-03 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
20 383
-2.8%
99,09
2 019 804
USD
|
20 383
-2.8%
|
99,09
|
2 019 804
USD
|
|
2022-11-07 |
2022-11-03 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
214 617
-22.9%
98,68
21 178 084
USD
|
214 617
-22.9%
|
98,68
|
21 178 084
USD
|
|
2022-11-03 |
2022-11-02 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
94 339
-11.9%
100,40
9 471 739
USD
|
94 339
-11.9%
|
100,40
|
9 471 739
USD
|
|
2022-11-03 |
2022-11-02 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
205 661
-20.6%
99,68
20 500 103
USD
|
205 661
-20.6%
|
99,68
|
20 500 103
USD
|
|
2022-11-03 |
2022-11-01 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
700
-0.1%
101,05
70 733
USD
|
700
-0.1%
|
101,05
|
70 733
USD
|
|
2022-11-03 |
2022-11-01 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
96 981
-12.1%
100,22
9 719 843
USD
|
96 981
-12.1%
|
100,22
|
9 719 843
USD
|
|
2022-11-03 |
2022-11-01 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
202 319
-20.1%
99,61
20 152 287
USD
|
202 319
-20.1%
|
99,61
|
20 152 287
USD
|
|
2022-11-01 |
2022-10-31 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
229 302
-24.5%
101,03
23 167 321
USD
|
229 302
-24.5%
|
101,03
|
23 167 321
USD
|
|
2022-11-01 |
2022-10-31 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
70 698
-7.0%
99,82
7 056 770
USD
|
70 698
-7.0%
|
99,82
|
7 056 770
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Zachary Jennifer
EVP, General Counsel
Dirigeant
|
65 487
-63.3%
99,85
6 538 877
USD
|
65 487
-63.3%
|
99,85
|
6 538 877
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Zachary Jennifer
EVP, General Counsel
Dirigeant
|
99 768
-49.1%
99,07
9 884 016
USD
|
99 768
-49.1%
|
99,07
|
9 884 016
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Dirigeant
|
164 557
-54.6%
100,26
16 499 094
USD
|
164 557
-54.6%
|
100,26
|
16 499 094
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Oosthuizen Johannes Jacobus
President, U.S. Market
Dirigeant
|
3 633
-25.0%
100,21
364 065
USD
|
3 633
-25.0%
|
100,21
|
364 065
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Dirigeant
|
100 292
-68.7%
100,10
10 039 380
USD
|
100 292
-68.7%
|
100,10
|
10 039 380
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Karachun Rita A
Sr. VP Fince-Global Controller
Dirigeant
|
31 997
-43.8%
100,34
3 210 685
USD
|
31 997
-43.8%
|
100,34
|
3 210 685
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
178 363
-20.2%
100,80
17 978 687
USD
|
178 363
-20.2%
|
100,80
|
17 978 687
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
313 232
-26.1%
100,25
31 402 730
USD
|
313 232
-26.1%
|
100,25
|
31 402 730
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
75 489
-5.9%
99,15
7 484 855
USD
|
75 489
-5.9%
|
99,15
|
7 484 855
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
8 000
-19.9%
98,84
790 720
USD
|
8 000
-19.9%
|
98,84
|
790 720
USD
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
MIZELL STEVEN
EVP, Chief HR Officer
Dirigeant
|
17 000
-29.7%
100,00
1 700 000
USD
|
17 000
-29.7%
|
100,00
|
1 700 000
USD
|
|
2021-11-10 |
2021-11-09 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
29 615
-4.8%
83,23
2 464 865
USD
|
29 615
-4.8%
|
83,23
|
2 464 865
USD
|
|
2021-11-10 |
2021-11-09 |
V
Vente
|
FRAZIER KENNETH C
Executive Chair
Administrateur exécutif
|
634 266
-50.7%
82,22
52 146 496
USD
|
634 266
-50.7%
|
82,22
|
52 146 496
USD
|
|
2021-11-05 |
2021-11-04 |
V
Vente
|
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Dirigeant
|
29 782
-20.3%
90,40
2 692 299
USD
|
29 782
-20.3%
|
90,40
|
2 692 299
USD
|
|
2021-11-05 |
2021-11-04 |
V
Vente
|
Litchfield Caroline
EVP & CFO
Dirigeant
|
18 335
-43.2%
91,00
1 668 503
USD
|
18 335
-43.2%
|
91,00
|
1 668 503
USD
|
|
2021-11-04 |
2021-11-03 |
V
Vente
|
Karachun Rita A
Sr. VP Fince-Global Controller
Dirigeant
|
25 000
-41.1%
88,45
2 211 215
USD
|
25 000
-41.1%
|
88,45
|
2 211 215
USD
|
|